Clinical Drug development is my profession, my specific expertise is the translation of clinical strategies into feasible and targeted studies with predictable timelines and budget. The starting point are clear and plausible clinical development plans and study protocols that consider patient needs and are covincing to investigators, Ethincs Committees and Health Authorities.I lead the Boehringer-Ingelheim Protocol Challenge Committee, look after study protocol standards and processes. As a member of working groups within TransCelerate, a non-profit organization that works across the biopharmaceutical research and development, I contribute to the development of global protocol standards. As a trainer at CenTrial, Tübingen, Germany I suport the education of MSC students of Clinical Research.I have more than 10 years of active study management experience (phase I to III, including two mega trials) as investigator, study director or line manager to study teams and worked in In both, large pharma and CROs.I am a M.D. specialized in Clinical Pharmacology and with clinical experience in Internal Medicine and Anesthesiology.